Cookson 1986.

Methods	Allocation: randomised ‐ seperate sequences for males and females. Blindness: double. Duration: 1 year. Statistics: last observation carried forward.
Participants	History: 1 year of treatment with fluphenazine decanoate, overweight BMI 25+, physically fit, stable during prev yr. N= 19. Age: range HD 26‐57 yrs/ FD 35‐60 yrs. Sex: 9 M, 10 F. Setting: community (depot injection clinic).
Interventions	1. Haloperidol decanoate: dose mean not specified, frequency same as previous depot. N=10. 2. Fluphenazine decanoate: dose mean not specified. N=9. Dose ratio: 4:1 (HD/FD).
Outcomes	Leaving the study early. Unable to use ‐ Mental state (CPRS, Kraweicka ‐Goldberg Scale ‐ no data). Side effects (Simpson & Angus Scale/ AIMS ‐ no data). Physiological measures (prolactin), weight measures ‐ non clinical outcomes, data not usuable).
Notes	No usuable continuous data. Authors contacted ‐ no reply.
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear